311224
Risk Assessment for the Potential Emergence of Dengue and Chikungunya Viruses in New Orleans, Louisiana
As suggested by World Health Organization guidelines, the framework establishes a multi-faceted response to disease control and incorporates operational research for evidence-based decision-making. Partnerships were established through previous collaborative door-to-door efforts with city agencies including New Orleans Fire, Police, Sanitation and Code Enforcement Departments. Discussions were initiated with public health epidemiologists to improve surveillance efforts and perform outreach to physicians. Cooperative agreements were established with regional mosquito abatement programs in the event that additional support would be needed. Surveillance for disease vectors was increased and treatment interventions were evaluated for efficacy. We believe this framework will strengthen response capacity and provide for targeted public education and control measures in advance of a potential outbreak in New Orleans.
Learning Areas:
Environmental health sciencesLearning Objectives:
Evaluate the potential for disease emergence based on vector populations
Describe the partnerships needed to maintain an adequate surveillance and reponse effort
Compare dengue and Chikungunya disease emergence factors to West Nile virus
Keyword(s): Environmental Health, Local Public Health Agencies
Qualified on the content I am responsible for because: I have been an Entomologist with the New Orleans Mosquito Control Board for 3 years during which I supervised the response to the 2012 WNV epidemic. I have a MSPH in Tropical Medicine from Tulane University and am completing my PhD. I was previously an Epidemiologist in the Louisiana Department of Health and Hospitals,Infectious Disease Epidemiology Section. I have the ability to understand and explain human epidemiology and vector ecology of mosquito-borne disease.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.